TGFB1 and breast cancer: Interestingly, trastuzumab treatment can increase the immune evasive properties of BC cells through the induced secretion of TGF-β, IL-6 and other immunosuppressive cytokines that, in turn, recruit immunosuppressive cells (165, 166).